Ind-Swift Labs.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE915B01019
  • NSEID: INDSWFTLAB
  • BSEID: 532305
INR
136.80
-2.35 (-1.69%)
BSENSE

Feb 10

BSE+NSE Vol: 8.07 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 393806,
    "name": "Ind-Swift Labs.",
    "stock_name": "Ind-Swift Labs.",
    "full_name": "Ind-Swift Laboratories Ltd",
    "name_url": "stocks-analysis/ind-swift-labs",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "136.80",
    "chg": -2.35,
    "chgp": "-1.69%",
    "dir": -1,
    "prev_price": "139.15",
    "mcapval": "1,136.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 532305,
    "symbol": "INDSWFTLAB",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE915B01019",
    "curr_date": "Feb 10",
    "curr_time": "",
    "bse_nse_vol": "8.07 lacs",
    "exc_status": "Active",
    "traded_date": "Feb 10, 2026",
    "traded_date_str": "2026 02 10",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/ind-swift-labs-393806-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "text": "Part of MojoOne Strategy",
      "type": "MN",
      "url": "https://www.marketsmojo.com/mojopro/strategy/2",
      "ismore": 0,
      "all_data": [],
      "is_blur": 1,
      "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/ind-swift-labs-393806-0&utm_source=Spage_Score_PartofStrategies"
    }
  },
  "news": {
    "results": [
      {
        "title": "Ind-Swift Laboratories Ltd Hits New 52-Week High of Rs.143",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ind-swift-laboratories-ltd-hits-new-52-week-high-of-rs143-3831064",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/IndSwiftLaborat_priceRelatedfactors_3831064.png",
        "date": "2026-02-10 11:06:38",
        "description": "Ind-Swift Laboratories Ltd has reached a significant milestone by hitting a new 52-week high of Rs.143, marking a strong rally in the Pharmaceuticals & Biotechnology sector. The stock’s sustained momentum over the past week has propelled it well above key moving averages, reflecting robust market performance amid a broadly positive Sensex environment."
      },
      {
        "title": "Ind-Swift Laboratories Ltd Hits New 52-Week High at Rs.139.25",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ind-swift-laboratories-ltd-hits-new-52-week-high-at-rs13925-3828780",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/IndSwiftLaborat_priceRelatedfactors_3828780.png",
        "date": "2026-02-09 12:45:14",
        "description": "Ind-Swift Laboratories Ltd has surged to a fresh 52-week high of Rs.139.25, marking a significant milestone in its stock performance. This new peak reflects strong momentum in the pharmaceuticals and biotechnology sector, with the stock outperforming its peers and broader market indices."
      },
      {
        "title": "Ind-Swift Laboratories Gains 16.20%: 5 Key Factors Driving the Surge",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ind-swift-laboratories-gains-1620-5-key-factors-driving-the-surge-3826728",
        "imagepath": "",
        "date": "2026-02-07 17:18:44",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>2 Feb:</strong> Stock opens at Rs.108.50 amid technical momentum shift</p>\n                    <p><strong>3 Feb:</strong> Mixed technical signals with mild bullish stance</p>\n                    <p><strong>4 Feb:</strong> Sideways trend amid divergent indicator signals</p>\n                    <p><strong>5 Feb:</strong> New 52-week high at Rs.124.6 and Golden Cross formation</p>\n                    <p><strong>6 Feb:</strong> New 52-week high at Rs.128.6 and Mojo Grade upgraded to Hold</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.113.34</div></div>\n    ..."
      },
      {
        "title": "Ind-Swift Laboratories Ltd Hits New 52-Week High at Rs.128.6",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ind-swift-laboratories-ltd-hits-new-52-week-high-at-rs1286-3824302",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/IndSwiftLaborat_priceRelatedfactors_3824302.png",
        "date": "2026-02-06 11:12:06",
        "description": "Ind-Swift Laboratories Ltd has reached a significant milestone by hitting a new 52-week high of Rs.128.6, marking a notable surge in its stock price amid a period of sustained gains and positive momentum within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Ind-Swift Laboratories Ltd Upgraded to Hold on Strong Financial and Technical Momentum",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ind-swift-laboratories-ltd-upgraded-to-hold-on-strong-financial-and-technical-momentum-3823753",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/IndSwiftLaborat_mojoScore_3823753.png",
        "date": "2026-02-06 08:09:36",
        "description": "Ind-Swift Laboratories Ltd has seen its investment rating upgraded from Sell to Hold, reflecting significant improvements across financial performance, valuation metrics, technical indicators, and overall quality assessment. This upgrade follows a robust quarter ending December 2025, with the company demonstrating strong sales growth, profitability gains, and bullish technical signals that have collectively enhanced investor confidence."
      },
      {
        "title": "Ind-Swift Laboratories Ltd Sees Bullish Momentum Shift Amid Technical Upgrades",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ind-swift-laboratories-ltd-sees-bullish-momentum-shift-amid-technical-upgrades-3823554",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/IndSwiftLaborat_technicaldot_3823554.png",
        "date": "2026-02-06 08:00:56",
        "description": "Ind-Swift Laboratories Ltd has demonstrated a notable shift in technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This transition is underpinned by a confluence of positive signals from key technical indicators such as MACD, moving averages, and Bollinger Bands, suggesting an improving outlook for the pharmaceutical and biotechnology company amid a volatile market backdrop."
      },
      {
        "title": "Ind-Swift Laboratories Ltd Forms Golden Cross, Signalling Potential Bullish Breakout",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ind-swift-laboratories-ltd-forms-golden-cross-signalling-potential-bullish-breakout-3822786",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/IndSwiftLaborat_goldencross_3822786.png",
        "date": "2026-02-05 18:00:12",
        "description": "Ind-Swift Laboratories Ltd has recently formed a Golden Cross, a significant technical indicator where the 50-day moving average (DMA) has crossed above the 200-day moving average. This development often signals a bullish breakout and a potential long-term shift in momentum, suggesting renewed investor confidence in the pharmaceutical and biotechnology company."
      },
      {
        "title": "Ind-Swift Laboratories Ltd Hits New 52-Week High at Rs.124.6",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ind-swift-laboratories-ltd-hits-new-52-week-high-at-rs1246-3822511",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/IndSwiftLaborat_priceRelatedfactors_3822511.png",
        "date": "2026-02-05 12:35:27",
        "description": "Ind-Swift Laboratories Ltd, a key player in the Pharmaceuticals & Biotechnology sector, reached a significant milestone today by hitting a new 52-week high of Rs.124.6, marking a notable surge in its stock price and reflecting strong momentum in recent trading sessions."
      },
      {
        "title": "Ind-Swift Laboratories Ltd Shows Technical Momentum Shift Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ind-swift-laboratories-ltd-shows-technical-momentum-shift-amid-mixed-indicator-signals-3821585",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/IndSwiftLaborat_technicaldot_3821585.png",
        "date": "2026-02-05 08:01:24",
        "description": "Ind-Swift Laboratories Ltd has exhibited a notable shift in technical momentum, moving from a sideways trend to a mildly bullish stance, supported by a mix of bullish and bearish signals across key technical indicators. Despite a recent upgrade in its Mojo Grade from Strong Sell to Sell, the stock’s price action and momentum metrics suggest cautious optimism amid ongoing volatility in the Pharmaceuticals & Biotechnology sector."
      }
    ],
    "total": 167,
    "sid": "393806",
    "stock_news_url": "https://www.marketsmojo.com/news/ind-swift-laboratories-393806"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
      "datetime": "04-Feb-2026",
      "details": "Please refer attached pdf.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Monitoring Agency Report",
      "datetime": "03-Feb-2026",
      "details": "Please find enclosed Monitoring Agency Report for the quarter ended Dec. 31 2025.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "02-Feb-2026",
      "details": "Please refer attached pdf.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Ind-Swift Laboratories Ltd has declared <strong>10%</strong> dividend, ex-date: 20 Sep 11",
          "dt": "2011-09-20",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views

Ind-Swift Laboratories Gains 16.20%: 5 Key Factors Driving the Surge

2026-02-07 17:18:44

Key Events This Week

2 Feb: Stock opens at Rs.108.50 amid technical momentum shift

3 Feb: Mixed technical signals with mild bullish stance

4 Feb: Sideways trend amid divergent indicator signals

5 Feb: New 52-week high at Rs.124.6 and Golden Cross formation

6 Feb: New 52-week high at Rs.128.6 and Mojo Grade upgraded to Hold

stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Investor Presentation

04-Feb-2026 | Source : BSE

Please refer attached pdf.

Announcement under Regulation 30 (LODR)-Monitoring Agency Report

03-Feb-2026 | Source : BSE

Please find enclosed Monitoring Agency Report for the quarter ended Dec. 31 2025.

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

02-Feb-2026 | Source : BSE

Please refer attached pdf.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Ind-Swift Laboratories Ltd has declared 10% dividend, ex-date: 20 Sep 11

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available